Volume 17, Number 11—November 2011
Mosquito-associated Dengue Virus, Key West, Florida, USA, 2010
Highlight and copy the desired format.
|EID||Graham AS, Pruszynski CA, Hribar LJ, DeMay DJ, Tambasco AN, Hartley AE, et al. Mosquito-associated Dengue Virus, Key West, Florida, USA, 2010. Emerg Infect Dis. 2011;17(11):2074-2075. https://dx.doi.org/10.3201/eid1711.110419|
|AMA||Graham AS, Pruszynski CA, Hribar LJ, et al. Mosquito-associated Dengue Virus, Key West, Florida, USA, 2010. Emerging Infectious Diseases. 2011;17(11):2074-2075. doi:10.3201/eid1711.110419.|
|APA||Graham, A. S., Pruszynski, C. A., Hribar, L. J., DeMay, D. J., Tambasco, A. N., Hartley, A. E....Isern, S. (2011). Mosquito-associated Dengue Virus, Key West, Florida, USA, 2010. Emerging Infectious Diseases, 17(11), 2074-2075. https://dx.doi.org/10.3201/eid1711.110419.|
To the Editor: Except for sporadic cases along the Texas–Mexico border, local transmission of dengue virus (DENV) has not occurred in the contiguous United States since 1946. In 2009, DENV was diagnosed in a vacationer to Key West, Florida (1). Subsequently, 25 other cases were reported that year, transmission was confirmed by detection of DENV serotype 1 (DENV-1) in local mosquitoes, and a random serosurvey showed evidence of recent DENV infection in 5.4% of Key West residents (1). Transmission continued in 2010, and an additional 63 cases were confirmed (2). We used PCR amplification and sequence analysis of virus identified from mosquito collections during 2010 to identify the closest relatives, probable geographic origin, and divergence time of the Key West DENV.
A total of 1,178 pools of Aedes aegypti mosquitoes were collected in Monroe County, Florida, during January 27–December 17, 2010 (Figure A1, panel A), by using BG-Sentinel (Biogents, Regensburg, Germany) or CDC (Clarke, Roselle, IL, USA) light traps, and stored at −80°C. Reverse transcription PCR was conducted on each pool by using primers designed to amplify all 4 DENV serotypes, followed by seminested PCR with serotype-specific primers (3). Results from 2 Key West mosquito pools collected on June 25 and 30 showed a positive first-round reverse transcription PCR and a positive second-round PCR specific for DENV-1. A third Key West pool collected on August 27 showed only a positive second-round PCR specific for DENV-1. No other DENV serotypes were detected.
DENV-1–specific primers (5′-GGGCCTTGAGACACCCAGG-3′ and 5′-CCTCCCATGCCTTCCCAATGGC-3′) were used to amplify products encompassing the envelope (E) gene region and parts of the premembrane and nonstructural 1 genes from the pools collected on June 25 and 30. PCR products were sequenced by using amplification and internal primers to provide double or triple coverage (Functional Biosciences, Madison, WI, USA). The sequences from these 2 pools were identical (GenBank accession no. JF519855). We used ClustalX (4) to align the Key West sequences with 175 nonredundant American DENV-1 sequences from the National Center for Biotechnology Information Virus Variation database (5) and 9 additional DENV-1 subgenomic E sequences from GenBank, which provided a comprehensive set of American DENV-1 sequences, including several isolates from Hawaii (USA) and Easter Island (Chile) that grouped with Asian DENV-1 clades as an outgroup. Maximum-likelihood phylogenetic analysis of the 1,484-nt E gene region was conducted by using SeaView software (6).
The analysis showed that American DENV-1 strains clustered by geography and by year of collection (Figure A1, panel B). This clustering might be the result of lineage replacement that has been described in DENV-1 (7). Additionally, clustering might be influenced by serotype prevalence or sampling bias. For example, the sequence database contains few Caribbean isolates from after 2000 and few Central or South American isolates from before 2000. The Key West sequence grouped as a member of a large clade of recent viruses from Central America that was separated from Caribbean and South American viruses with a well-supported bootstrap value (86%) and relatively long branch length. The closest relatives were 2 strains isolated in Nicaragua in 2006 and 2008. The bootstrap support for this grouping was 100%. Phylogenetic analyses with neighbor-joining, maximum-parsimony, and Bayesian methods gave trees with similar topologies, including clear separation of most recent Central American isolates into 1 clade, as well as grouping of the Key West sequence with the same 2 isolates from Nicaragua (data not shown). No protein coding changes between these strains were identified, which suggests purifying selection for an optimum phenotype. There were 8 synonymous differences over the 1,708-nt amplified region between the Key West and Nicaragua 2008 sequences. Previous molecular clock determinations for DENV-1 provided a range of 2.5–7.0 × 10–4 substitutions per nucleotide per year (8). This calculation produced an estimate of a 6.7–18.7-year divergence time between the Key West virus and the most closely related Nicaragua strain. When during this time the ancestor of Key West DENV was introduced to Florida is unknown.
Analysis of the entire Key West DENV-1 genome may help pinpoint the origin and address the possibility of selective pressure on other genes or recombination events (9). Given the recent reports of DENV in residents of other Florida counties who had no travel histories (2), monitoring of Key West and other nearby urban areas for evidence of local DENV transmission should continue.
We thank the staff of the Florida Keys Mosquito Control District for assistance with mosquito collection, Chris Geiger for use of laboratory space, and Michael Shannon and Ram Samudrala for computing assistance.
This work was supported in part by Defense Threat Reduction Agency awards HDTRA1-09-1-0004 and HDTRA1-10-1-0009 to S.F.M. and S.I.
- Centers for Disease Control and Prevention. Locally acquired dengue—Key West, Florida, 2009–2010. MMWR Morb Mortal Wkly Rep. 2010;59:577–81.
- Anil L, Stanek D, Blackmore C, Stark L, Mock V. Florida arbovirus surveillance week 52: December 26–January 1, 2011 [cited 2011 Mar 18]. http://www.doh.state.fl.us/Environment/medicine/arboviral/pdfs/2010/2010Week52ArbovirusReport_1_1_2011.pdf
- Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase–polymerase chain reaction. J Clin Microbiol. 1992;30:545–51.
- Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;24:4876–82.
- Resch W, Zaslavsky L, Kiryutin B, Rozanov M, Bao Y, Tatusova TA. Virus variation resources at the National Center for Biotechnology Information: dengue virus. BMC Microbiol. 2009;9:65.
- Gouy M, Guindon S, Gascuel O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol. 2010;27:221–4.
- Zhang C, Mammen MP Jr, Chinnawirotpisan P, Klungthong C, Rodpradit P, Monkongdee P, Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J Virol. 2005;79:15123–30.
- Twiddy SS, Holmes EC, Rambaut A. Inferring the rate and time-scale of dengue virus evolution. Mol Biol Evol. 2003;20:122–9.
- Carvalho SES, Martin DP, Oliveira LM, Ribeiro BM, Nagata T. Comparative analysis of American dengue virus type 1 full-genome sequences. Virus Genes. 2010;40:60–6.
- Figure A1. A) Mosquito collection locations, Key West, Florida, USA, January 27–December 17, 2010. Inset shows Key West. Red squares indicate locations of dengue virus serotype 1 (DENV-1)–positive mosquito pools. Yellow...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Sharon Isern, Department of Biological Sciences, College of Arts and Sciences, AB7 304, Florida Gulf Coast University, 10501 FGCU Blvd South, Fort Myers, FL 33965-6565, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: October 24, 2011
- Page last updated: October 24, 2011
- Page last reviewed: October 24, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)